This site is intended for UK healthcare professionals
Medscape UK Univadis Logo
Medscape UK Univadis Logo

Welcome to the new home of Guidelines in Practice

For Primary Care| Video

Asthma Guidance and Best Practice—Dr Kevin Gruffydd-Jones' Guidelines Live Session

Asthma Guidance and Best Practice

In this speaker session filmed at Guidelines Live 2022, Dr Kevin Gruffydd-Jones reviews asthma guidance from NICE, Scottish Intercollegiate Guidelines Network/British Thoracic Society, and Global Initiative for Asthma including the key recommendations, similarities and differences, and any changes from previous versions. Patient case studies are included to provide practical advice on implementing the guidance.

Keen to Learn More?

View our selection of Guidelines summaries at, and read these Guidelines in Practice expert articles:

View our Guidelines Live 2022 special companion editions of Guidelines and Guidelines in Practice, produced to provide further information on sessions covered in the main agenda.

New Reflection Record

Reflection is important for continuous learning and development, and is a critical part of the revalidation process for UK healthcare professionals. Our new Reflection Record is designed to help you reflect on your learning after reading a Guidelines summary or a Guidelines in Practice article, or after viewing a Guidelines in Practice video. Click here to access the Reflection Record and add it to your personal development portfolio.

Guidelines Live is a must-attend live event focussed on essential guidance-related continuing professional development (CPD). Developed by specialist GPs and GP appraisers, Guidelines Live 2023 will feature 12 clinical streams of educational sessions on the latest clinical guidance for the whole primary care team, including GPs, nurses, and pharmacists. Dedicate 2 days to your continuing professional development by registering to attend Guidelines Live 2023 at the summer offer rate of only £49.

Guidelines Live is an educational event made possible by sponsorship from organisations including pharmaceutical companies. Sponsors have had no input into the agenda of the meeting unless through sponsored session(s) as indicated on the main programme.